methamphetamine has been researched along with Schizophrenia in 136 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (13.24) | 18.7374 |
| 1990's | 16 (11.76) | 18.2507 |
| 2000's | 36 (26.47) | 29.6817 |
| 2010's | 47 (34.56) | 24.3611 |
| 2020's | 19 (13.97) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Liu, X; Wang, G; Yang, Y; Yu, X; Zeng, K | 1 |
| Asmal, L; du Plessis, S; Emsley, R; Hendrikse, CB; Luckhoff, HK; Olivier, MR; Phahladira, L; Scheffler, F; Smit, AM | 1 |
| Chang, MH; Chiou, LC; Cook, J; Knutson, DE; Kubota, H; Lee, HJ; Lee, MT; Mihovilovic, M; Mouri, A; Nabeshima, T; Sieghart, W; Wu, CY | 1 |
| Han, SB; Hong, JT; Kim, S; Son, DJ; Webster, MJ; Yeo, IJ; Yun, J | 1 |
| Fort, J; Malone, GW; Mohammad-Amin, H | 1 |
| Deng, H; Guan, F; Jia, X; Jiang, W; Kong, Z; Lai, W; Li, P; Wang, J; Yang, M; Ye, C; Zhao, M | 1 |
| Chen, T; Guan, FL; Han, W; Zhang, JB; Zhao, LR; Zhu, L | 1 |
| Dong, G; Kaibuchi, K; Liao, J; Liu, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Ozaki, N; Sawahata, M; Wulaer, B; Yamada, K; Zhu, W | 1 |
| Al-Mayah, QS; Hashim, ZH; Hussein, MM; Mohammed, SM | 1 |
| Bousman, CA; Danilewitz, M; Frankow, L; Honer, WG; Mahmood, H; Mathew, N; Poonia, S; Rafizadeh, R; Schütz, CG | 1 |
| Chiang, M; Du, J; Fan, X; Harrington, A; Lombardi, D; Makrum, U; Shukair, N; Sitthichai, R; Zhao, M | 1 |
| Liu, T; London, ED; Yang, C; Yang, M | 1 |
| Alikhani, M; Brand, S; Farnia, V; Farshchian, F; Farshchian, N; Sadeghi Bahmani, D | 1 |
| Piel, JL; Reisner, AD | 1 |
| Ito, K; Koga, M; Kusumi, I; Oka, M | 1 |
| Hume, C; Massey, S; van den Buuse, M | 1 |
| Chesworth, R; Karl, T; Rosa-Porto, R; Yao, S | 1 |
| Likhitsathian, S; Maneeton, B; Maneeton, N; Oon-Arom, A; Srisurapanont, M; Suradom, C; Suttajit, S | 1 |
| Hada, K; Itoh, N; Kushima, I; Mizoguchi, H; Mori, D; Nabeshima, T; Nagai, T; Ozaki, N; Sawahata, M; Sobue, A; Wulaer, B; Yamada, K | 1 |
| Deng, H; Hu, W; Jia, X; Jiang, W; Kong, Z; Lai, W; Liu, T; Ren, P; Xie, C; Yang, M; Zhang, B; Zhao, M; Zhou, H | 1 |
| Babinska, Z; Micale, V; Ruda-Kucerova, J; Stark, T | 1 |
| Feng, J; Jia, M; Liu, J; Wen, X; Zhang, G; Zhang, W | 1 |
| Iamjan, SA; Nudmamud-Thanoi, S; Reynolds, GP; Thanoi, S; Watiktinkorn, P | 1 |
| Baldwin, DS; Howells, FM; Hsieh, JH; Stein, DJ; Temmingh, HS; van Dijen, AV | 1 |
| Burns, R; Calabria, B; Castle, D; McKetin, R; Voce, A | 1 |
| Cai, WX; Hu, Q; Li, C; Liu, C; Tang, T; Zang, YY; Zhang, S | 1 |
| Dassa, D; Dircks, S; Dubois, M | 1 |
| Kimura, H; Kunugi, A; Suzuki, A; Suzuki, M; Suzuki, N; Tanaka, M | 1 |
| Balan, S; Esaki, K; Fujita, Y; Hashimoto, K; Hayashi-Takagi, A; Hino, M; Hisano, Y; Iwayama, Y; Kakita, A; Kunii, Y; Maekawa, M; Mataga, N; Matsumoto, J; Nagaoka, A; Nozaki, Y; Ohba, H; Ohnishi, T; Shimamoto-Mitsuyama, C; Tan, Y; Toyoshima, M; Watanabe, A; Yabe, H; Yoshikawa, T | 1 |
| Lee, A; McInnis, P | 1 |
| Dada, S; de Clercq, C; Kader, R; Lewis, I; Parker, JS; Parry, CD; Plüddemann, A; Temmingh, H; van Heerden, S | 1 |
| Chen, YW; Kao, HY; Lai, WS; Min, MY | 1 |
| Colantuoni, C; Furukori, K; Harada, K; Hiyama, H; Hookway, C; Huang, B; Jaaro-Peled, H; Kano, SI; Kondo, MA; Matsuoka, N; Ni, K; Pevsner, J; Pou, S; Sawa, A; Seshadri, S; Tajinda, K | 1 |
| Aleksic, B; Aoyama-Uehara, K; Hashimoto, R; Ikeda, M; Iwata, N; Iyo, M; Kawamura, Y; Kondo, N; Miyagawa, T; Naruse, N; Nishida, N; Okahisa, Y; Ozaki, N; Sasaki, T; Sora, I; Takeda, M; Tokunaga, K; Ujike, H; Won, M | 1 |
| Fujita, Y; Hashimoto, K; Ishima, T; Zhang, L | 1 |
| Bahorik, AL; Eack, SM; Newhill, CE | 1 |
| He, Z; Li, H; Li, Q; Lu, Q; Mei, X; Xiao, E | 1 |
| Corlett, PR; Ermakova, AO; Fletcher, PC; Murray, GK; Ramachandra, P | 1 |
| Kanazawa, M; Kubota, H; Mori, T; Rahmadi, M; Shibasaki, M; Suzuki, T | 1 |
| Chen, CC; Huang, YH; Lin, CH; Wu, HC | 1 |
| Akiyama, K; Arime, Y; Fukumura, R; Gondo, Y; Mekada, K; Miura, I; Wakana, S; Yoshiki, A | 1 |
| Chen, CK; Chen, TT; Chen, YC; Huang, MC; Lin, SK; Ree, SC; Wang, LJ | 1 |
| Ishii-Takahashi, A; Kasai, K; Kawasaki, S; Kinoshita, A; Koike, S; Nakakita, M; Nishimura, Y; Ohtani, T; Okada, N; Okazaki, Y; Sakakibara, E; Satomura, Y; Takahashi, K; Takizawa, R | 1 |
| Bramness, JG; Medhus, SE; Rognli, EB | 1 |
| Kato, K; Kunugi, H; Ogawa, S; Ota, M; Wakabayashi, C | 1 |
| Iida, J; Kimoto, S; Kishimoto, N; Kishimoto, T; Makinodan, M; Matsuda, Y; Matsuoka, K; Morimoto, T; Nishihata, Y; Ota, T; Takahashi, M; Takata, T; Takebayashi, Y; Tanimura, Y; Toritsuka, M; Yamamuro, K; Yoshino, H | 1 |
| Kato, K; Kunugi, H; Masuda, C; Ogawa, S; Ota, M | 1 |
| Brownell, AL; Choi, JK; Hattori, S; Ishii, S; Jenkins, BG; Kil, KE; Miyakawa, T; Takagi, T; Zhu, A | 1 |
| Amchova, P; Babinska, Z; Drago, F; Micale, V; Ruda-Kucerova, J; Stark, T; Sulcova, A | 1 |
| Furukawa-Hibi, Y; Iwata, M; Jinno, H; Kikuchi, Y; Matsuoka, T; Miyamoto, Y; Nabeshima, T; Nitta, A; Okamoto, Y; Sumiyoshi, T; Takada, T; Uehara, T; Uno, K | 1 |
| Fukada, M; Kawaguchi, Y; Mamiya, T; Nakayama, A; Yao, TP | 1 |
| Howells, FM; Shelly, J; Sibeko, G; Sinclair, H; Stein, DJ; Temmingh, H; Uhlmann, A; Wilson, D | 1 |
| Pieterse, D; Temmingh, H; Vogel, W | 1 |
| Fukuda, T; Hiranita, T; Kira, J; Kitaichi, K; Miyakawa, T; Nakayama, KI; Sakae, N; Tatsumi, Y; Yamada, M; Yamamoto, T; Yamasaki, N; Yoshikawa, H | 1 |
| Aleksic, B; Harano, M; Hori, T; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ohkouchi, T; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
| Harano, M; Hori, T; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ozaki, N; Sekine, Y; Sora, I; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
| Arai, S; Ibi, D; Kamei, H; Kim, HC; Mizoguchi, H; Nagai, T; Takuma, K; Yamada, K | 1 |
| Davidson, G; Keltner, NL | 1 |
| Inada, T; Iwata, N; Iyo, M; Kawashima, K; Kinoshita, Y; Kishi, T; Kitajima, T; Naitoh, H; Okochi, T; Okumura, T; Ozaki, N; Sora, I; Tsunoka, T; Uchimura, N; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
| Akiniwa, H; Ikeda, T; Morita, N; Nakatani, Y; Umeno, M | 1 |
| Abekawa, T; Inoue, T; Ito, K; Koyama, T; Nakato, Y | 1 |
| Itoh, H; Kurachi, M; Matsuoka, T; Seo, T; Sumiyoshi, T; Suzuki, M; Uehara, T | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S; Nakato, Y | 2 |
| Arrang, JM; Motawaj, M | 1 |
| Hashimoto, K; Iyo, M; Kanahara, N; Okamura, N; Sekine, Y; Tadokoro, S | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakato, Y | 1 |
| Correll, CU; Inada, T; Iwata, N; Iyo, M; Kishi, T; Kitajima, T; Okochi, T; Ozaki, N; Sora, I; Uchimura, N; Ujike, H; Yamada, M | 1 |
| Allebeck, P; Arenovich, T; Boileau, I; Callaghan, RC; Cunningham, JK; Kish, SJ; Remington, G; Sajeev, G | 1 |
| Gururajan, A; Klug, M; Manning, EE; van den Buuse, M | 1 |
| Bramness, JG; Holm, B; Medhus, S; Mordal, J; Mørland, J | 1 |
| Bramness, JG; Franck, J; Gundersen, ØH; Guterstam, J; Konstenius, M; Løberg, EM; Medhus, S; Rognli, EB; Tanum, L | 1 |
| AKABANE, Y; TAKAHASHI, Y | 1 |
| DE CAROLIS, V; GIBERTI, F; ROSSI, R | 2 |
| JOHNSEN, G | 1 |
| PROUT, CT | 1 |
| DAVISON, K | 1 |
| SCHWARTZ, M; SHAGASS, C | 1 |
| Chaki, S; Hirota, S; Kawashima, N; Okuyama, S | 1 |
| Ball, D; Chen, CK; Chiang, YL; Hsiao, CC; Lee, CH; Lin, SK; Loh, EW; Murray, RM; Ree, SC; Sham, PC | 1 |
| Matsuoka, N; Mutoh, S; Shirakawa, K; Tada, M | 1 |
| Ikemoto, S; Yui, K | 1 |
| Ballard, ME; Bennani, YL; Bitner, RS; Browman, KE; Buckley, MJ; Cowart, MD; Decker, MW; Drescher, KU; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Komater, VA; Krueger, KM; Lemaire, M; Marsh, K; Miner, H; Pan, JB; Porsolt, RD; Radek, RJ; Rueter, LE; Sullivan, JP; Wetter, J; Yao, BB; Zhang, M | 1 |
| Härtel-Petri, R; Rodler, R; Schmeisser, U; Steinmann, J; Wolfersdorf, M | 1 |
| Harano, M; Imamura, T; Inada, T; Iwata, N; Iyo, M; Kishimoto, M; Komiyama, T; Kuroda, S; Morio, A; Morita, Y; Nomura, A; Ohtani, K; Ozaki, N; Sakai, A; Sekine, Y; Sora, I; Tanaka, Y; Uchida, N; Ujike, H; Yamada, M | 1 |
| Furukawa, T; Harano, M; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kitajima, T; Komiyama, T; Nishiyama, T; Ozaki, N; Sekine, Y; Sora, I; Suzuki, T; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
| Ball, D; Chen, CK; Lin, SK; Loh, el-W; Murray, RM; Sham, PC | 1 |
| Bagorda, F; Lehmann, K; Teuchert-Noodt, G | 1 |
| Itoh, H; Kurachi, M; Seeman, P; Sumiyoshi, T; Tsunoda, M; Uehara, T | 1 |
| Hashimoto, K; Ishikura, H; Iyo, M; Kishimoto, T; Ozawa, K; Shimizu, E | 1 |
| Bagorda, F; Lehmann, K; Teuchert-Noodt, G; Witte, AV | 1 |
| Harano, M; Ikeda, M; Inada, T; Iwata, N; Iyo, M; Kinoshita, Y; Kishi, T; Kitajima, T; Komiyama, T; Ozaki, N; Sekine, Y; Sora, I; Suzuki, T; Ujike, H; Yamada, M; Yamanouchi, Y | 1 |
| Abekawa, T; Ito, K; Koyama, T; Nakagawa, S | 1 |
| Itoh, H; Kurachi, M; Matsuoka, T; Sumiyoshi, T; Uehara, T | 1 |
| Abekawa, T; Fang, YR; Ito, K; Koyama, T; Li, XB | 1 |
| Ary, AW; Lominac, KD; Szumlinski, KK | 1 |
| Pasic, J; Ries, RK; Roy-Byrne, PP; Russo, JE | 1 |
| Chung, YK; Ha, HJ; Jang, J; Jung, MW; Kim, YB | 1 |
| Hashimoto, K | 1 |
| Brady, AM; Glick, SD; McCallum, SE; O'Donnell, P | 1 |
| Kanaya, T; Sarai, K; Sera, H; Yonekawa, M | 1 |
| Kaneno, S; Shimazono, Y | 1 |
| Iwanami, A; Kamijima, K; Kanamori, R; Kaneko, T; Suga, I | 1 |
| Akiyama, K; Kanzaki, A; Tsuchida, K; Ujike, H | 1 |
| Iwanami, A; Kaneko, T; Nakatani, Y; Suga, I; Sugiyama, A | 1 |
| Matsushima, E; Shimazono, Y | 1 |
| Abekawa, T; Ito, K; Koyama, T; Ohmori, T | 1 |
| Yamamoto, J | 1 |
| Ishigooka, J; Miura, S; Nagata, E; Tanaka, T; Watanabe, S | 1 |
| Fukumaki, Y; Hamamura, M; Higasa, K; Iwaki, A; Kimuro, Y; Okouchi, J; Ozawa, H | 1 |
| Jodo, E; Kayama, Y; Matsuki, T; Niwa, S; Suzuki, Y; Takeuchi, S | 1 |
| Ali, SF; Angrist, B; Bracha, SH; Duncan, GE; Goto, K; Ikemoto, S; Ishiguro, T; Lieberman, JA; Sheitman, BB; Yui, K | 1 |
| Kurachi, M; Sumiyoshi, T; Tanii, Y; Uehara, T | 1 |
| Leung, LS; Ma, J | 1 |
| Hamada, K; Shiratani, T; Takenouchi, K; Takigawa, M; Wang, G; Wang, HD | 1 |
| Horikomi, K; Miwa, T; Takahashi, S | 1 |
| Goto, K; Ikemoto, S; Ishiguro, T; Yui, K | 1 |
| Kato, K; Kobayashi, M; Niwa, S; Ono, M; Shishido, K; Shishido, T | 1 |
| Semba, J; Suhara, T; Tanaka, N; Wakuta, M | 1 |
| Sato, M | 1 |
| Akiyama, K; Kanzaki, A; Okumura, K; Otsuki, S; Ujike, H | 1 |
| Akiyama, K; Kanzaki, A; Otsuki, S; Tsuchida, H; Ujike, H | 1 |
| Machiyama, Y | 1 |
| Hamamura, T; Numachi, Y; Sato, M | 1 |
| Tomiyama, G | 1 |
| Ando, H; Ando, K; Kojima, T; Matsushima, E; Nakajima, K; Shimazono, Y; Shiraishi, H | 1 |
| Barker, ET; Mason, MH | 1 |
| Kato, H; Moroji, T; Sakashita, A; Yamashita, I; Yamazaki, K | 1 |
| Casey, TM; Niswander, GD; Sanborn, DE | 1 |
| Askar, AM; Rakhawy, YT; Shaheen, O | 1 |
| Andrews, G; Kiloh, LG; Neilson, M | 1 |
| Bell, DS; Kirkby, RJ; Preston, AC | 1 |
| Machiyama, U; Utena, H | 1 |
| Kozuma, Y; Miyagawa, T; Takaki, M; Tatetsu, S | 1 |
| Ban, TA; Kral, VA; Lehmann, HE; Silver, D | 1 |
18 review(s) available for methamphetamine and Schizophrenia
| Article | Year |
|---|---|
Methamphetamine-associated psychosis: Clinical presentation, biological basis, and treatment options.
Topics: Antipsychotic Agents; Cognitive Behavioral Therapy; Electroacupuncture; Exercise Therapy; Humans; Inflammation; Methamphetamine; Neurotransmitter Agents; Oxidative Stress; Prefrontal Cortex; Psychoses, Substance-Induced; Schizophrenia | 2019 |
Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Haloperidol; Humans; Methamphetamine; Network Meta-Analysis; Olanzapine; Patient Dropouts; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia | 2021 |
Electroencephalographic delta/alpha frequency activity differentiates psychotic disorders: a study of schizophrenia, bipolar disorder and methamphetamine-induced psychotic disorder.
Topics: Adult; Alpha Rhythm; Biomarkers; Bipolar Disorder; Case-Control Studies; Delta Rhythm; Female; Humans; Male; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; Young Adult | 2018 |
[Antibiotic drug minocycline: a potential therapeutic drug for methamphetamine-related disorders].
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Humans; Methamphetamine; Minocycline; Schizophrenia; Substance-Related Disorders | 2013 |
[Two methods of support for methamphetamine concurrent disorder--comparison of "schizophrenia support" model and "dependence support" model].
Topics: Adult; Female; Humans; Male; Methamphetamine; Models, Theoretical; Schizophrenia; Self-Help Groups; Social Support; Substance-Related Disorders; Young Adult | 2010 |
Drugs of abuse and increased risk of psychosis development.
Topics: Age of Onset; Animals; Behavioral Symptoms; Brain; Cannabis; Dopamine; Dopamine Uptake Inhibitors; Functional Neuroimaging; Genetic Predisposition to Disease; Glutamic Acid; Humans; Illicit Drugs; Methamphetamine; Models, Animal; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Substance-Related Disorders | 2012 |
Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?
Topics: Amphetamine; Diagnosis, Differential; Disease Susceptibility; Humans; Methamphetamine; Models, Psychological; Psychoses, Substance-Induced; Risk Factors; Schizophrenia | 2012 |
Neuropharmacological profile of an atypical antipsychotic, NRA0562.
Topics: Animals; Antipsychotic Agents; Brain; Dopamine Antagonists; Humans; Methamphetamine; Motor Activity; Neuropharmacology; Piperidines; Receptors, Dopamine; Schizophrenia; Serotonin Antagonists; Thiazoles | 2003 |
[Stress sensitization induced by stressor and methamphetamine].
Topics: Amphetamine; Animals; Behavior, Animal; Brain; Central Nervous System Stimulants; Disease Models, Animal; Guinea Pigs; Hallucinations; Humans; Methamphetamine; Mice; Rats; Schizophrenia; Stress, Physiological; Substance-Related Disorders; Synaptic Transmission | 2004 |
Homers regulate drug-induced neuroplasticity: implications for addiction.
Topics: Animals; Carrier Proteins; Cocaine; Ethanol; Glutamic Acid; Homer Scaffolding Proteins; Humans; Methamphetamine; Neuronal Plasticity; Nucleus Accumbens; Prefrontal Cortex; Schizophrenia; Substance-Related Disorders | 2008 |
[Minocycline as a therapeutic drug for methamphetamine use disorders].
Topics: Animals; Anti-Bacterial Agents; Brain; Disease Models, Animal; Humans; Methamphetamine; Minocycline; N-Methyl-3,4-methylenedioxyamphetamine; Positron-Emission Tomography; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders | 2008 |
Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia.
Topics: Animals; Behavior, Animal; Dopamine; Humans; Methamphetamine; Models, Biological; Rats; Receptors, Dopamine D1; Receptors, sigma; Recurrence; Schizophrenia; Synaptic Transmission | 1994 |
Behavioral and neuroimaging studies on schizophrenia in Japan.
Topics: Brain; Chronic Disease; Exploratory Behavior; Eye Movements; Fixation, Ocular; Humans; Incidence; Japan; Magnetic Resonance Imaging; Maze Learning; Methamphetamine; Play and Playthings; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1995 |
[Context-dependent sensitization: reconsideration and a hypothesis].
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Classical; Disease Models, Animal; Methamphetamine; Rats; Schizophrenia; Substance-Related Disorders | 1997 |
Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization.
Topics: Animals; Brain Chemistry; Cocaine-Related Disorders; Hallucinogens; Humans; Methamphetamine; Phencyclidine; Predictive Value of Tests; Psychoses, Substance-Induced; Recurrence; Schizophrenia; Sensory Thresholds; Sympathomimetics | 1999 |
Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia.
Topics: Amphetamines; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Humans; Japan; Methamphetamine; Psychoses, Substance-Induced; Research; Schizophrenia; Substance-Related Disorders | 2000 |
[Basic and clinical studies on methampetamine-related psychosis].
Topics: Adult; Animals; Crime; Diagnosis, Differential; Dopamine; Forensic Psychiatry; Humans; Japan; Male; Methamphetamine; Middle Aged; Nerve Net; Psychoses, Substance-Induced; Schizophrenia; Substance-Related Disorders; Time Factors | 2002 |
Relapse of paranoid psychotic state in methamphetamine model of schizophrenia.
Topics: Animals; Cocaine; Cross-Sectional Studies; Dopamine; Female; Humans; Japan; Male; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology; Terminology as Topic | 1992 |
118 other study(ies) available for methamphetamine and Schizophrenia
| Article | Year |
|---|---|
Altered fecal microbiota composition in individuals who abuse methamphetamine.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Biodiversity; Case-Control Studies; Cognition; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Methamphetamine; Middle Aged; Phylogeny; Principal Component Analysis; Schizophrenia; Schizophrenic Psychology | 2021 |
The associations of cannabis and methamphetamine use with cognitive performance over the first 2 years of treatment in schizophrenia spectrum disorders.
Topics: Cannabis; Cognition; Humans; Longitudinal Studies; Methamphetamine; Neuropsychological Tests; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology | 2022 |
Targeting α6GABA
Topics: Animals; Disease Models, Animal; gamma-Aminobutyric Acid; Humans; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, GABA-A; Schizophrenia | 2022 |
Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors.
Topics: Animals; Brain; Endothelial Cells; Inflammation; Methamphetamine; Mice; Receptors, Tumor Necrosis Factor, Type II; Schizophrenia; Tumor Necrosis Factor-alpha | 2023 |
Cotard's syndrome in a patient with schizophrenia-spectrum disorder.
Topics: Delusions; Humans; Methamphetamine; Schizophrenia | 2022 |
Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia.
Topics: Brain; Frontal Lobe; Gray Matter; Humans; Magnetic Resonance Imaging; Methamphetamine; Psychotic Disorders; Schizophrenia | 2022 |
Application Prospect of Integrative Omics in Forensic Identification of Methamphetamine-Associated Psychosis.
Topics: Diagnosis, Differential; Humans; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia | 2022 |
Rho kinase inhibitors ameliorate cognitive impairment in a male mouse model of methamphetamine-induced schizophrenia.
Topics: Animals; Clozapine; Cognitive Dysfunction; Haloperidol; Male; Methamphetamine; Mice; Monomeric GTP-Binding Proteins; Protein Kinase Inhibitors; rho-Associated Kinases; Schizophrenia | 2023 |
Serum brain-derived neurotrophic factor levels in patients with schizophrenia and methamphetamine addiction: correlation with Mini-Mental State Examination (MMSE).
Topics: Amphetamine-Related Disorders; Brain-Derived Neurotrophic Factor; Case-Control Studies; Cognitive Dysfunction; Humans; Methamphetamine; Schizophrenia | 2023 |
Association of clozapine treatment and rate of methamphetamine or amphetamine relapses and abstinence among individuals with concurrent schizophrenia spectrum and amphetamine use disorder: A retrospective cohort study.
Topics: Amphetamine; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Female; Humans; Male; Methamphetamine; Recurrence; Retrospective Studies; Schizophrenia; Substance-Related Disorders | 2023 |
Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
Topics: Adult; Age of Onset; Amphetamine-Related Disorders; Brief Psychiatric Rating Scale; Central Nervous System Stimulants; Female; Humans; Male; Methamphetamine; Middle Aged; Paranoid Disorders; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Time Factors | 2020 |
Comparisons of Voxel-Based Morphometric Brain Volumes of Individuals with Methamphetamine-Induced Psychotic Disorder and Schizophrenia Spectrum Disorder and Healthy Controls.
Topics: Adult; Amygdala; Atrophy; Central Nervous System Stimulants; Female; Gray Matter; Hippocampus; Humans; Limbic System; Male; Methamphetamine; Parahippocampal Gyrus; Psychoses, Substance-Induced; Putamen; Schizophrenia; White Matter; Young Adult | 2020 |
Letter to the Editor-Is Chronic Methamphetamine-Induced Psychosis A Mental Disease for the Purposes of Insanity?
Topics: Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Insanity Defense; Methamphetamine; Psychoses, Substance-Induced; Schizophrenia; United States | 2020 |
Changes in subunit composition of NMDA receptors in animal models of schizophrenia by repeated administration of methamphetamine.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Male; Methamphetamine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA; Schizophrenia | 2020 |
The Effect of Chronic Methamphetamine Treatment on Schizophrenia Endophenotypes in Heterozygous Reelin Mice: Implications for Schizophrenia.
Topics: Animals; Cell Adhesion Molecules, Neuronal; Endophenotypes; Extracellular Matrix Proteins; Female; Injections, Intraperitoneal; Locomotion; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Nerve Tissue Proteins; Reelin Protein; Schizophrenia; Serine Endopeptidases | 2020 |
Sex-specific sensitivity to methamphetamine-induced schizophrenia-relevant behaviours in
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression Profiling; Locomotion; Male; Methamphetamine; Mice; Mice, Transgenic; Neuregulin-1; Prefrontal Cortex; Prepulse Inhibition; Psychotropic Drugs; Schizophrenia; Schizophrenic Psychology; Sex Factors; Substance-Related Disorders | 2021 |
Mice carrying a schizophrenia-associated mutation of the Arhgap10 gene are vulnerable to the effects of methamphetamine treatment on cognitive function: association with morphological abnormalities in striatal neurons.
Topics: Animals; Cognition; Corpus Striatum; Dendritic Spines; Discrimination, Psychological; Gene Expression Regulation; GTPase-Activating Proteins; Methamphetamine; Mice, Inbred C57BL; Mutation; Myosin-Light-Chain Phosphatase; Neurons; Nucleus Accumbens; rhoA GTP-Binding Protein; RNA, Messenger; Schizophrenia | 2021 |
Brain dysfunction of methamphetamine-associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit.
Topics: Adult; Amphetamine-Related Disorders; Brain Mapping; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Patient Acuity; Psychoses, Substance-Induced; Schizophrenia; Temporal Lobe | 2021 |
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
Topics: Analysis of Variance; Animals; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ketamine; Locomotion; Methamphetamine; Methylazoxymethanol Acetate; Rats; Rats, Sprague-Dawley; Schizophrenia; Self Administration | 2017 |
Downregulation of 5-hydroxytryptamine
Topics: Animals; Attention; Central Nervous System Stimulants; Cognition; Disease Models, Animal; Down-Regulation; Executive Function; Gene Knockdown Techniques; Impulsive Behavior; Male; Maze Learning; Memory; Methamphetamine; Mice, Inbred C57BL; Motor Activity; Phencyclidine; Prefrontal Cortex; Random Allocation; Receptors, Serotonin; Schizophrenia; Schizophrenic Psychology | 2018 |
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Brain-Derived Neurotrophic Factor; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, AMPA; Schizophrenia; Young Adult | 2018 |
The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Amphetamine; Amphetamine-Related Disorders; Australia; Female; Humans; Male; Methamphetamine; Middle Aged; Prospective Studies; Psychoses, Substance-Induced; Random Allocation; Schizophrenia; Young Adult | 2018 |
Changes in Gray Matter Density, Regional Homogeneity, and Functional Connectivity in Methamphetamine-Associated Psychosis: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study.
Topics: Adult; Brain; Brain Mapping; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Psychoses, Substance-Induced; Psychotic Disorders; Retrospective Studies; Schizophrenia; Young Adult | 2018 |
Psychotic Symptoms Associated With Superior Vena Cava Syndrome Following Methamphetamine Abuse.
Topics: Adult; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Male; Methamphetamine; Schizophrenia; Superior Vena Cava Syndrome; Young Adult | 2018 |
Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia.
Topics: Animals; Cognition; Disease Models, Animal; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Gene Expression Regulation; Haplorhini; Male; Maze Learning; Methamphetamine; Mice; Phencyclidine; Rats; Receptors, AMPA; Schizophrenia; Thiadiazines | 2019 |
Investigation of betaine as a novel psychotherapeutic for schizophrenia.
Topics: Animals; Betaine; Brain; Choline Dehydrogenase; Dietary Supplements; Disease Models, Animal; DNA Methylation; Genotype; Humans; Japan; Liver; Male; Methamphetamine; Mice; Oxidative Stress; Psychotropic Drugs; Quantitative Trait Loci; Schizophrenia | 2019 |
Methamphetamine use in an early psychosis service: a cross-sectional retrospective cohort study.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Cross-Sectional Studies; Female; Humans; Male; Methamphetamine; Neuropsychological Tests; New South Wales; Psychoses, Substance-Induced; Retrospective Studies; Schizophrenia; Young Adult | 2019 |
Monitoring the prevalence of methamphetamine-related presentations at psychiatric hospitals in Cape Town, South Africa.
Topics: Adolescent; Adult; Aggression; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Delusions; Developing Countries; Female; Hallucinations; Humans; Male; Methamphetamine; Middle Aged; Mood Disorders; Patient Admission; Patient Readmission; Psychoses, Substance-Induced; Schizophrenia; Sex Factors; South Africa; Urban Population; Young Adult | 2013 |
A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosis.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Neurons; Proto-Oncogene Proteins c-akt; Psychoses, Substance-Induced; Raclopride; Schizophrenia; Sex Factors | 2014 |
Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Astrocytes; Cell Cycle; Dibenzothiazepines; Disease Models, Animal; Frontal Lobe; Gene Expression; Haloperidol; In Situ Hybridization; Male; Methamphetamine; Mice; Neurons; Oligodendroglia; p21-Activated Kinases; Principal Component Analysis; Quetiapine Fumarate; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Schizophrenia | 2013 |
Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia.
Topics: Alleles; Amphetamine-Related Disorders; Asian People; Case-Control Studies; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Male; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2013 |
Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.
Topics: Adult; Amphetamine-Related Disorders; Cocaine-Related Disorders; Cognition; Cognition Disorders; Female; Hair; Humans; Male; Marijuana Smoking; Methamphetamine; Middle Aged; Radioimmunoassay; Schizophrenia; Schizophrenic Psychology | 2014 |
Methamphetamine enhances the development of schizophrenia in first-degree relatives of patients with schizophrenia.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Brain Mapping; Causality; China; Cognition Disorders; Dominance, Cerebral; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Methamphetamine; Neuropsychological Tests; Schizophrenia; Young Adult | 2014 |
Effects of methamphetamine administration on information gathering during probabilistic reasoning in healthy humans.
Topics: Adult; Decision Making; Delusions; Dopamine; Female; Healthy Volunteers; Humans; Male; Methamphetamine; Norepinephrine; Schizophrenia; Thinking; Young Adult | 2014 |
Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
Topics: Animals; Anisoles; Behavior, Animal; Disease Models, Animal; Fluvoxamine; Methamphetamine; Mice; Propylamines; Rats; Receptors, sigma; Reward; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor | 2013 |
Differences between patients with schizophrenia with and without co-occurring methamphetamine use disorders in a Taiwanese public psychiatric hospital.
Topics: Adult; Amphetamine-Related Disorders; Comorbidity; Female; Follow-Up Studies; Hospitalization; Hospitals, Psychiatric; Humans; Male; Methamphetamine; Middle Aged; Retrospective Studies; Schizophrenia; Taiwan | 2014 |
Effects of background mutations and single nucleotide polymorphisms (SNPs) on the Disc1 L100P behavioral phenotype associated with schizophrenia in mice.
Topics: Animals; Central Nervous System Stimulants; Disease Models, Animal; Exome; Female; Interpersonal Relations; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Motor Activity; Mutation; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Schizophrenia; Schizophrenic Psychology | 2014 |
Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
Topics: Adult; Amphetamine-Related Disorders; Cognition Disorders; Cross-Sectional Studies; Female; Humans; Longitudinal Studies; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Schizophrenia | 2015 |
Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Case-Control Studies; Central Nervous System Stimulants; Female; Hemoglobins; Humans; Inhibition, Psychological; Male; Methamphetamine; Neuropsychological Tests; Oxyhemoglobins; Prefrontal Cortex; Psychomotor Performance; Psychoses, Substance-Induced; Schizophrenia; Spectroscopy, Near-Infrared | 2016 |
[Amphetamine-induced psychosis or schizophrenia?].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Humans; Methamphetamine; Psychoses, Substance-Induced; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2015 |
Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
Topics: Animals; Benzamides; Biomarkers; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Rats; Receptors, Dopamine D2; Schizophrenia | 2015 |
Differential patterns of blood oxygenation in the prefrontal cortex between patients with methamphetamine-induced psychosis and schizophrenia.
Topics: Adult; Female; Humans; Male; Methamphetamine; Middle Aged; Oxygen; Prefrontal Cortex; Psychotic Disorders; Schizophrenia; Speech | 2015 |
Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Topics: Animals; Benzamides; Brain; Callithrix; Central Nervous System Stimulants; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Fluorodeoxyglucose F18; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia | 2015 |
Combined behavioral studies and in vivo imaging of inflammatory response and expression of mGlu5 receptors in schnurri-2 knockout mice.
Topics: Acetamides; Amphetamine; Animals; Brain; Carbon Radioisotopes; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; DNA-Binding Proteins; Exploratory Behavior; Fluorine Radioisotopes; Hippocampus; Inflammation; Methamphetamine; Mice, Knockout; Motor Activity; Nitriles; Positron-Emission Tomography; Pyridines; Radiopharmaceuticals; Receptor, Metabotropic Glutamate 5; Schizophrenia | 2015 |
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats.
Topics: Alcohol Drinking; Animals; Behavior, Animal; Disease Models, Animal; Female; Male; Methamphetamine; Methylazoxymethanol Acetate; Pregnancy; Rats; Rats, Sprague-Dawley; Schizophrenia; Sex Characteristics | 2017 |
Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.
Topics: Acetyltransferases; Animals; Case-Control Studies; CpG Islands; DNA Methylation; Humans; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Phenotype; Promoter Regions, Genetic; Schizophrenia | 2016 |
Dopaminergic abnormalities in Hdac6-deficient mice.
Topics: Animals; Apomorphine; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Dopaminergic Neurons; Histone Deacetylase 6; Male; Methamphetamine; Mice, 129 Strain; Mice, Knockout; Motor Activity; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Schizophrenia | 2016 |
First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
Topics: Adult; Delusions; Female; Hallucinations; Humans; Logistic Models; Male; Methamphetamine; Middle Aged; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia | 2016 |
Factors associated with readmission in South African adolescents discharged from two inpatient psychosocial rehabilitation units.
Topics: Adolescent; Alcoholism; Amphetamine-Related Disorders; Bipolar Disorder; Cohort Studies; Educational Status; Female; Hospital Units; Humans; Male; Marijuana Abuse; Methamphetamine; Multivariate Analysis; Patient Readmission; Psychiatric Rehabilitation; Psychoses, Substance-Induced; Retrospective Studies; Risk Factors; Schizophrenia; South Africa; Young Adult | 2016 |
Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants.
Topics: Animals; Base Sequence; Brain; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; DNA Primers; DNA-Binding Proteins; Dopamine; gamma-Aminobutyric Acid; Humans; Interneurons; Learning; Male; Memory; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Nerve Tissue Proteins; Phenotype; RNA, Messenger; Schizophrenia; Synaptic Transmission | 2008 |
Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Calcineurin; Case-Control Studies; Central Nervous System Stimulants; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Methamphetamine; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Schizophrenia | 2008 |
Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
Topics: Adult; Amphetamine-Related Disorders; Asian People; Female; Genotype; Glutamate-Cysteine Ligase; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Protein Subunits; Psychoses, Substance-Induced; Schizophrenia | 2008 |
GABAB receptor agonist baclofen improves methamphetamine-induced cognitive deficit in mice.
Topics: Animals; Baclofen; Cognition Disorders; Dose-Response Relationship, Drug; GABA Agonists; Male; Memory; Methamphetamine; Mice; Mice, Inbred ICR; Schizophrenia; Time Factors | 2009 |
The normalization of paranoia.
Topics: Amphetamine-Related Disorders; Arousal; Brain; Cues; Culture; Dopamine; Humans; Methamphetamine; Paranoid Disorders; Psychotropic Drugs; Schizophrenia; Social Change; Social Conditions; Social Environment; Thinking | 2009 |
Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.
Topics: Amphetamine-Related Disorders; Asian People; Case-Control Studies; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Japan; Methamphetamine; Mutation; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Receptor, Serotonin, 5-HT2A; Receptors, Metabotropic Glutamate; Regression Analysis; Schizophrenia | 2010 |
Lamotrigine blocks the initiation and expression of repeated high-dose methamphetamine-induced prepulse inhibition deficit in rats.
Topics: Animals; Anticonvulsants; Central Nervous System Stimulants; Disease Models, Animal; Lamotrigine; Male; Methamphetamine; Neural Inhibition; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia; Triazines | 2010 |
Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Humans; Locomotion; Methamphetamine; Motor Activity; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia | 2010 |
Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Apoptosis; Aripiprazole; Behavioral Symptoms; Disease Models, Animal; Dizocilpine Maleate; Haloperidol; In Situ Nick-End Labeling; Inhibition, Psychological; Male; Methamphetamine; Microdialysis; Motor Activity; Neuroprotective Agents; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Reflex, Startle; Schizophrenia | 2011 |
Ciproxifan, a histamine H₃-receptor antagonist / inverse agonist, modulates methamphetamine-induced sensitization in mice.
Topics: Animals; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Histamine Agonists; Histamine H3 Antagonists; Humans; Imidazoles; Male; Methamphetamine; Mice; Motor Activity; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Thiourea | 2011 |
Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Haloperidol; Long-Term Care; Male; Methamphetamine; Motor Activity; Piperazines; Psychoses, Substance-Induced; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2012 |
Developmental GABAergic deficit enhances methamphetamine-induced apoptosis.
Topics: Animals; Apoptosis; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Sensory Gating; Time Factors | 2011 |
Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population.
Topics: Alleles; Amphetamine-Related Disorders; Asian People; Bipolar Disorder; Case-Control Studies; Central Nervous System Stimulants; Depressive Disorder, Major; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Genotype; Haplotypes; HapMap Project; Humans; Male; Methamphetamine; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Schizophrenia | 2011 |
Methamphetamine use and schizophrenia: a population-based cohort study in California.
Topics: Adult; Amphetamine-Related Disorders; California; Cohort Studies; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Methamphetamine; Middle Aged; Risk Factors; Schizophrenia; Schizophrenic Psychology | 2012 |
A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards.
Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Chi-Square Distribution; Cross-Sectional Studies; Female; Hospitals, Psychiatric; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 2013 |
Brain hexokinase activity. Investigation of brain tissue from rats receiving methamphetamine hydrochloride (Methedrine) and from schizophrenics.
Topics: Amphetamine; Amphetamines; Animals; Brain; Hexokinase; Methamphetamine; Phosphotransferases; Rats; Schizophrenia | 1960 |
[The "stimulation threshold" for methylamphetamine by means of fractionated Weckanalysis].
Topics: Bipolar Disorder; Mental Disorders; Methamphetamine; Neurotic Disorders; Psychotic Disorders; Schizophrenia | 1962 |
[Preliminary contribution to the study of fractionated Weckanalysis with methylphenidylate].
Topics: Bipolar Disorder; Humans; Mental Disorders; Methamphetamine; Neurotic Disorders; Psychotic Disorders; Schizophrenia | 1962 |
[CLINICAL ASPECTS OF MODEL PSYCHOSES].
Topics: Anorexia Nervosa; Convulsive Therapy; Hospitals, Psychiatric; Humans; Insulin; Lysergic Acid Diethylamide; Mental Disorders; Methamphetamine; Methylphenidate; Neurotic Disorders; Obsessive-Compulsive Disorder; Paraphilic Disorders; Pharmacology; Psychotic Disorders; Schizophrenia | 1964 |
REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
Topics: Alcoholism; Amobarbital; Amphetamine; Amphetamines; Barbiturates; Dextroamphetamine; Hospitals, Psychiatric; Humans; Methamphetamine; Narcotics; Paranoid Disorders; Phenmetrazine; Psychoses, Substance-Induced; Psychotic Disorders; Schizophrenia; Substance Withdrawal Syndrome; Substance-Related Disorders; Toxicology | 1964 |
EPISODIC DEPERSONALIZATION; OBSERVATIONS ON 7 PATIENTS.
Topics: Alcoholic Beverages; Amitriptyline; Amobarbital; Cochlea; Convulsive Therapy; Depersonalization; Depression; Dextroamphetamine; Diagnosis, Differential; Electroconvulsive Therapy; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Humans; Insulin; Methamphetamine; Schizophrenia; Temporal Lobe; Vestibule, Labyrinth | 1964 |
EVOKED POTENTIAL STUDIES IN PSYCHIATRIC PATIENTS.
Topics: Amobarbital; Antisocial Personality Disorder; Biomedical Research; Bipolar Disorder; Electric Stimulation; Electroconvulsive Therapy; Electroencephalography; Evoked Potentials; Humans; Hypnosis; Imipramine; Lysergic Acid Diethylamide; Mental Disorders; Methamphetamine; Psychophysiology; Psychotic Disorders; Reflex; Schizophrenia; Ulnar Nerve; Vision, Ocular | 1964 |
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
Topics: Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Antisocial Personality Disorder; Causality; Central Nervous System Stimulants; Comorbidity; Depressive Disorder, Major; Disease Susceptibility; Female; Hospitals, Psychiatric; Humans; Male; Methamphetamine; Personality Assessment; Prisons; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Risk Factors; Schizoid Personality Disorder; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Taiwan | 2003 |
Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Catalepsy; Chlorpromazine; Dibenzothiazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Haloperidol; Hyperkinesis; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Piperazines; Pyridines; Quetiapine Fumarate; Receptor, Serotonin, 5-HT1A; Risperidone; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists | 2004 |
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 re
Topics: Aging; Animals; Avoidance Learning; Benzofurans; Central Nervous System Stimulants; Cognition Disorders; Dose-Response Relationship, Drug; Drinking; Electroencephalography; Histamine Antagonists; Hyperkinesis; Male; Maze Learning; Methamphetamine; Mice; Mice, Inbred DBA; Microdialysis; Neurons; Neurotransmitter Agents; Pyrrolidines; Rats; Rats, Inbred SHR; Receptors, Histamine H3; Reflex, Startle; Schizophrenia; Social Behavior | 2005 |
[Increasing prevalence of amphetamine--and methamphetamine-induced psychosis].
Topics: Amphetamine; Amphetamine-Related Disorders; Central Nervous System Stimulants; Cross-Sectional Studies; Diagnosis, Differential; Forecasting; Germany; Humans; Methamphetamine; Paranoid Disorders; Psychoses, Substance-Induced; Schizophrenia | 2005 |
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
Topics: Adult; Age of Onset; Amidohydrolases; Amino Acid Sequence; Amino Acid Substitution; Amphetamine-Related Disorders; Cannabinoid Receptor Modulators; Case-Control Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Japan; Male; Methamphetamine; Middle Aged; Mutation; Polymorphism, Genetic; Schizophrenia | 2005 |
Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.
Topics: Adolescent; Adult; Aged; Algorithms; Alleles; Amphetamine-Related Disorders; Case-Control Studies; Central Nervous System Stimulants; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Haplotypes; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Receptors, GABA-A; Receptors, GABA-B; Schizophrenia | 2005 |
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.
Topics: Adult; Amphetamine-Related Disorders; Comorbidity; Family; Female; Humans; Interviews as Topic; Male; Mental Disorders; Methamphetamine; Prevalence; Psychotic Disorders; Risk Factors; Schizophrenia | 2005 |
Isolation rearing or methamphetamine traumatisation induce a "dysconnection" of prefrontal efferents in gerbils: implications for schizophrenia.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Disease Models, Animal; Dopamine; Efferent Pathways; Gerbillinae; Glutamic Acid; Lysine; Male; Methamphetamine; Models, Neurological; Parietal Lobe; Prefrontal Cortex; Presynaptic Terminals; Schizophrenia; Social Isolation; Synaptic Transmission | 2006 |
Increased proportion of high-affinity dopamine D2 receptors in rats with excitotoxic damage of the entorhinal cortex, an animal model of schizophrenia.
Topics: Animals; Benzazepines; Disease Models, Animal; Dopamine Antagonists; Entorhinal Cortex; Functional Laterality; Male; Methamphetamine; Rats; Rats, Wistar; Receptors, Dopamine D2; Schizophrenia | 2005 |
Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia.
Topics: Animals; Animals, Newborn; Antibodies, Viral; Brain; Clozapine; Cognition; Cytokines; Disease Models, Animal; Exploratory Behavior; Female; Form Perception; Mental Recall; Methamphetamine; Mice; Mice, Inbred BALB C; Motor Activity; Neural Inhibition; Neuroimmunomodulation; Orientation; Poly I-C; Pregnancy; Pregnancy Complications, Infectious; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Reflex, Startle; Schizophrenia; Virus Diseases | 2006 |
Contralateral prefrontal projections in gerbils mature abnormally after early methamphetamine trauma and isolated rearing.
Topics: Animals; Dopamine Agents; Functional Laterality; Gerbillinae; Image Processing, Computer-Assisted; Methamphetamine; Neural Pathways; Prefrontal Cortex; Schizophrenia; Social Isolation | 2007 |
Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia.
Topics: Adult; Amphetamine-Related Disorders; Arrestins; beta-Arrestin 2; beta-Arrestins; Case-Control Studies; Chi-Square Distribution; Female; Humans; Linkage Disequilibrium; Male; Methamphetamine; Middle Aged; Polymorphism, Single Nucleotide; Schizophrenia | 2007 |
Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine
Topics: Age Factors; Animals; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Male; Methamphetamine; Motor Activity; Neurons; Parvalbumins; Phencyclidine; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2007 |
Effect of prefrontal cortex inactivation on behavioral and neurochemical abnormalities in rats with excitotoxic lesions of the entorhinal cortex.
Topics: Amygdala; Anesthetics, Local; Animals; Denervation; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Entorhinal Cortex; Lidocaine; Limbic System; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neural Pathways; Nucleus Accumbens; Prefrontal Cortex; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenia; Synaptic Transmission | 2007 |
Effects of behavioral and neurochemical changes on adult excitotoxic lesion of the ventral hippocampus.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Hippocampus; Male; Methamphetamine; Motor Activity; Neurodegenerative Diseases; Neurotoxins; Rats; Rats, Sprague-Dawley; Schizophrenia | 2007 |
Methamphetamine users in the psychiatric emergency services: a case-control study.
Topics: Adult; Age Factors; Case-Control Studies; Comorbidity; Emergency Services, Psychiatric; Female; Forensic Psychiatry; Hospitalization; Humans; Hypertension; Length of Stay; Male; Methamphetamine; Police; Recurrence; Referral and Consultation; Retrospective Studies; Schizophrenia; Sex Factors; Substance-Related Disorders; Suicide, Attempted; Tachycardia | 2007 |
Olanzapine and risperidone block a high dose of methamphetamine-induced schizophrenia-like behavioral abnormalities and accompanied apoptosis in the medial prefrontal cortex.
Topics: Animals; Antipsychotic Agents; Apoptosis; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; In Situ Nick-End Labeling; Male; Methamphetamine; Motor Activity; Neural Inhibition; Neuroprotective Agents; Olanzapine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Risperidone; Schizophrenia; Time Factors | 2008 |
Effects of methamphetamine on single unit activity in rat medial prefrontal cortex in vivo.
Topics: Action Potentials; Animals; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Male; Methamphetamine; Neurons; Prefrontal Cortex; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stochastic Processes; Synaptic Transmission | 2007 |
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia.
Topics: Amphetamine-Related Disorders; Animals; Animals, Newborn; Behavior, Addictive; Behavior, Animal; Central Nervous System Stimulants; Diagnosis, Dual (Psychiatry); Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hippocampus; Male; Methamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Schizophrenia; Self Administration | 2008 |
[The effects of chronic methamphetamine and single haloperidol injections on thiamine and its phosphate ester levels in the rat brain].
Topics: Animals; Brain; Disease Models, Animal; Haloperidol; Humans; Male; Methamphetamine; Rats; Rats, Inbred Strains; Schizophrenia; Thiamine; Thiamine Monophosphate; Thiamine Pyrophosphate; Thiamine Triphosphate; Time Factors | 1984 |
Decreased in vivo [3H]spiroperidol binding in rat brain after repeated methamphetamine administration.
Topics: Animals; Brain; Butyrophenones; Drug Tolerance; Humans; Male; Methamphetamine; Motor Activity; Rats; Receptors, Dopamine; Schizophrenia; Spiperone; Stereotyped Behavior | 1981 |
Reduced attention-related negative potentials in methamphetamine psychosis.
Topics: Adult; Attention; Auditory Perception; Diagnosis, Differential; Discrimination, Psychological; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1995 |
P300 component of event-related potentials in methamphetamine psychosis and schizophrenia.
Topics: Adult; Discrimination, Psychological; Electroencephalography; Evoked Potentials, Auditory; Female; Humans; Male; Methamphetamine; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Reaction Time; Schizophrenia; Schizophrenic Psychology; Substance-Related Disorders | 1994 |
Cortical and hippocampal EEG power spectra in animal models of schizophrenia produced with methamphetamine, cocaine, and phencyclidine.
Topics: Adrenergic Agents; Animals; Cerebral Cortex; Cocaine; Disease Models, Animal; Electroencephalography; Hallucinogens; Hippocampus; Male; Methamphetamine; Phencyclidine; Rabbits; Schizophrenia | 1997 |
Partial inhibition of reverse tolerance by a high dose of ritanserin or low dose of haloperidol in methamphetamine-sensitized rat.
Topics: Animals; Dopamine; Dopamine Antagonists; Drug Therapy, Combination; Drug Tolerance; Haloperidol; Locomotion; Male; Methamphetamine; Motor Activity; Rats; Rats, Wistar; Ritanserin; Schizophrenia; Serotonin; Serotonin Antagonists | 1998 |
Differential decreases in c-fos and aldolase C mRNA expression in the rat cerebellum after repeated administration of methamphetamine.
Topics: Animals; Blotting, Northern; Cerebellum; Dopamine; Dopamine Agents; Fructose-Bisphosphate Aldolase; Gene Expression Regulation, Enzymologic; In Situ Hybridization; Male; Methamphetamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Schizophrenia | 1999 |
Effects of repeated administration of methamphetamine on P3-like potentials in rats.
Topics: Animals; Central Nervous System Stimulants; Cerebral Cortex; Conditioning, Operant; Disease Models, Animal; Drug Administration Schedule; Event-Related Potentials, P300; Male; Methamphetamine; Motor Activity; Psychoses, Substance-Induced; Rats; Rats, Sprague-Dawley; Schizophrenia; Stereotypic Movement Disorder; Time Factors | 1999 |
Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Animals, Newborn; Brain; Caudate Nucleus; Disease Models, Animal; Dopamine; Dopamine Agonists; Entorhinal Cortex; Female; Homovanillic Acid; Methamphetamine; Microdialysis; Neurotoxins; Nucleus Accumbens; Prefrontal Cortex; Quinolinic Acid; Rats; Rats, Wistar; Schizophrenia; Temporal Lobe | 2000 |
Relation between hippocampal gamma waves and behavioral disturbances induced by phencyclidine and methamphetamine.
Topics: Animals; Arousal; Brain Mapping; Central Nervous System Stimulants; Disease Models, Animal; Electroencephalography; Evoked Potentials; Hallucinogens; Hippocampus; Male; Methamphetamine; Motor Activity; Phencyclidine; Psychomotor Performance; Rats; Rats, Long-Evans; Schizophrenia; Septum of Brain | 2000 |
Reciprocal information flow between prefrontal cortex and ventral tegmental area in an animal model of schizophrenia.
Topics: Animals; Brain; Central Nervous System Stimulants; Electroencephalography; Male; Methamphetamine; Motor Activity; Prefrontal Cortex; Rats; Rats, Wistar; Reference Values; Schizophrenia; Schizophrenic Psychology; Stereotyped Behavior; Tegmentum Mesencephali | 2000 |
Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Male; Methamphetamine; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, sigma; Schizophrenia; Sigma-1 Receptor; Stereotyped Behavior; Tartrates | 2000 |
Glycine reduces novelty- and methamphetamine-induced locomotor activity in neonatal ventral hippocampal damaged rats.
Topics: Animals; Disease Models, Animal; Glycine; Hippocampus; Hyperkinesis; Ibotenic Acid; Methamphetamine; Motor Activity; Rats; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2001 |
Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain.
Topics: Animals; Animals, Newborn; Dopamine; Methamphetamine; Neural Pathways; Neurons; Nucleus Accumbens; Phencyclidine; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Schizophrenia; Stereotyped Behavior; Ventral Tegmental Area | 2001 |
Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.
Topics: Animals; Male; Methamphetamine; Motor Activity; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Schizophrenia; Stereotyped Behavior | 1992 |
Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization.
Topics: Animals; Binding, Competitive; Dizocilpine Maleate; Drug Administration Schedule; Male; Methamphetamine; Motor Activity; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 1992 |
Chronic methamphetamine intoxication model of schizophrenia in animals.
Topics: Animals; Behavior, Animal; Cats; Disease Models, Animal; Female; Guinea Pigs; Male; Methamphetamine; Mice; Psychoses, Substance-Induced; Schizophrenia; Schizophrenic Psychology | 1992 |
Chronic schizophrenia-like states in methamphetamine psychosis.
Topics: Adult; Arousal; Diagnosis, Differential; Female; Humans; Male; Methamphetamine; Middle Aged; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Schizophrenia; Schizophrenia, Paranoid; Schizophrenic Psychology; Substance Abuse, Intravenous; Substance-Related Disorders; Thinking | 1990 |
Eye movements in acute, chronic, and remitted schizophrenics.
Topics: Acute Disease; Adult; Attention; Chronic Disease; Discrimination Learning; Dominance, Cerebral; Epilepsy, Temporal Lobe; Eye Movements; Female; Fixation, Ocular; Humans; Male; Mental Recall; Methamphetamine; Pattern Recognition, Visual; Psychiatric Status Rating Scales; Psychomotor Performance; Psychoses, Substance-Induced; Pursuit, Smooth; Reaction Time; Schizophrenia; Schizophrenic Psychology | 1990 |
Bubber behind bars.
Topics: Amobarbital; Antisocial Personality Disorder; Attitude to Health; Audiovisual Aids; Communication; Dextroamphetamine; History of Medicine; Hospitalization; Hospitals, Psychiatric; Humans; Imipramine; Interpersonal Relations; Lysergic Acid Diethylamide; Mental Disorders; Methamphetamine; Methods; Ontario; Patient Care Planning; Prisons; Psychotherapy; Schizophrenia; Scopolamine; Therapeutic Community; United States | 1968 |
Neuroendocrinological studies in mental disorders and psychotropic drugs. I. On the circadian rhythm of the plasma adrenocortical hormone in mental patients and methamphetamine- and chlorpromazine-treated animals.
Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Animals; Chlorpromazine; Circadian Rhythm; Corticosterone; Electroencephalography; Epilepsy; Fluorometry; Humans; Kidney; Male; Mental Disorders; Methamphetamine; Middle Aged; Paresis; Pneumoencephalography; Rats; Schizophrenia | 1969 |
Drug abusers, suicide attempters, and the MMPI.
Topics: Adolescent; Adult; Humans; Lysergic Acid Diethylamide; Male; Methamphetamine; MMPI; Personality Assessment; Schizophrenia; Substance-Related Disorders; Suicide | 1971 |
The quantitative assessment of the therapeutic effect of methamphetamine on psychiatric patients.
Topics: Adolescent; Adult; Humans; Injections, Intravenous; Male; Methamphetamine; Middle Aged; MMPI; Neurotic Disorders; Personality; Schizophrenia | 1970 |
Response of depressed patients to methylamphetamine.
Topics: Adjustment Disorders; Adult; Alcoholism; Bipolar Disorder; Female; Histrionic Personality Disorder; Humans; Injections, Intravenous; Male; Methamphetamine; Middle Aged; Neurotic Disorders; Personality Disorders; Psychological Tests; Psychotic Disorders; Schizophrenia; Self-Assessment; Sex Factors; Substance-Related Disorders | 1974 |
The effects of methylamphetamine on stereotyped behaviour, activity, startle, and orienting responses.
Topics: Animals; Behavior, Animal; Exploratory Behavior; Humans; Locomotion; Male; Methamphetamine; Motor Activity; Rats; Reflex, Startle; Schizophrenia | 1972 |
[Schizophrenia model in animals].
Topics: Animals; Behavior, Animal; Disease Models, Animal; Humans; Macaca; Male; Methamphetamine; Schizophrenia | 1971 |
[A study on the experimental production in the brain of histopathological changes resembling schizophrenia by chronic methamphetamine administration].
Topics: Animals; Brain; Guinea Pigs; Humans; Male; Methamphetamine; Microscopy, Electron; Psychoses, Substance-Induced; Schizophrenia | 1967 |
Experimental geriatrics. Selection and prediction of therapeutic responsiveness in geriatric patients.
Topics: Aged; Amobarbital; Analysis of Variance; Carbon Dioxide; Hospitalization; Humans; Methamphetamine; Neurocognitive Disorders; Paranoid Disorders; Psychiatric Status Rating Scales; Psychological Tests; Psychotic Disorders; Schizophrenia | 1968 |